Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma.
Mahalingam D, Espitia CM, Medina EC, Esquivel JA 2nd, Kelly KR, Bearss D, Choy G, Taverna P, Carew JS, Giles FJ, Nawrocki ST.
Mahalingam D, et al. Among authors: medina ec.
Br J Cancer. 2011 Nov 8;105(10):1563-73. doi: 10.1038/bjc.2011.426. Epub 2011 Oct 20.
Br J Cancer. 2011.
PMID: 22015557
Free PMC article.